AVATAR MEDICAL, LLC
Biotech · Private
A conformationally stable headless hemagglutinin (HA) protein immunogen for universal influenza vaccination, engineered with dityrosine crosslinks and site-specific protease cleavage sites.
avatarbiotechnologies.com →- Grants
- $3.6M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 7
- 0 granted · 7 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420152016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A Universal Flu Vaccine Based on Conformationally Locked Soluble Headless HA | $224,905 | |
| Federal grant | Department of Health and Human Services · Phase I · Dityrosine Locked Prefusion F Protein: A Path To A Protective RSV Vaccine | $296,818 | |
| Federal grant | Department of Health and Human Services · Phase II · Conformational Stabilization of the HIV-1 Env Trimer | $999,646 | |
| Federal grant | Department of Health and Human Services · Phase II · Dityrosine Locked Prefusion F Protein A Path To A Protective RSV Vaccine | $1,499,167 | |
| Federal grant | Department of Health and Human Services · Phase II · A Universal Flu Vaccine Based On Conformationally Locked Soluble Headless HA | $612,265 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2825 | CENTRILLION BIOSCIENCES, INC. | — | — |
| 2826 | Adaptimmune | — | $104M |
| 2827 | Civitas Therapeutics | — | $104M |
| 2828 | AVATAR MEDICAL, LLC | — | — |
| 2829 | NEPHROGEN INC. | — | — |
| 2830 | JUNIPERO THERAPEUTICS, INC. | — | — |
| 2831 | Inceptive Nucleics, Inc. | — | $100M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Influenza Hemagglutinin Proteins And Methods Of Use Thereofapplication
- Conformationally Stabilized Rsv Prefusion F Proteinsapplication
- Conformationally Stabilized Rsv Prefusion F Proteinsapplication
- Conformationally Stabilized Rsv Prefusion F Proteinsapplication
- Influenza Hemagglutinin Proteins And Methods Of Thereofapplication
- Protein Arrays And Methods Of Productionapplication
- Conformationally Stabilized Rsv Prefusion F Proteinsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.